Thirona LungQ

von Thirona

AI Application

Niedrige Vertrauensstufe

LungQ is Thirona's AI-powered quantitative CT analysis platform for pulmonary disease. It uses AI-driven segmentation and quantification to detect, measure, and track lung disease (COPD, cystic fibrosis, bronchiectasis, severe asthma) from thoracic CT scans, supporting pharmaceutical clinical trials (treatment efficacy assessment) and pulmonary interventions (AI-enabled bronchoscopic/surgical imaging). LungQ4 and LungQ v3.y.z hold current FDA 510(k) clearance and EU MDR CE marking (Class II/IIb) as regulated medical devices.